Chen
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
If Chen is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.
What’s changed
- IGF2BP3-Mediated m6A Modification of OLR1 mRNA Promotes Immune Evasion in CRC via the PI3K/AKT/mTOR Pathway. · J Immunother · 2026-08-13
- Qiming Partner Kan Chen to Present at 13th ARDD Meeting in Boston · Bioengineer.org · 2026-08-15 · usually covers Aging
- Adaptive Oxide Switching Devices for Scalable ESD Protection in AI Driven Microelectronics · nsf · 2026-10-15 · usually covers Federal Alignment
- New shinkansen model delivered to Taiwan · Japan Times — All News · 2026-08-16 · usually covers Japan
- High-dose furmonertinib plus bevacizumab and intrathecal pemetrexed for EGFR-RAD51 fusion-positive lung adenocarcinoma with leptomeningeal metastasis: Insights from serial CSF ctDNA monitoring · European Journal of Cancer · 2026-08-16 · usually covers Oncology
- Student Housing Investor Buys Foggy Bottom Residences: The D.C. Deal Sheet · Bisnow · 2026-08-15 · usually covers Commercial Real Estate
What the reporting says
It shows up alongside Colorectal Cancer (43), Wang (12), Immunotherapy (11), Zhang (11), AI (23), China (12), Google (9), Semiconductor (8).
Two steps out: Braf (through Colorectal Cancer, 43 shared stories on the weaker link); ctDNA (through Colorectal Cancer, 43 shared stories on the weaker link); KRAS (through Colorectal Cancer, 43 shared stories on the weaker link); MSI-H (through Colorectal Cancer, 43 shared stories on the weaker link).
Tracked since Apr 3, with coverage on 39 separate days — concentrated in Pubmed Targeted.